{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "ORPHAN DRUG|Designated/Withdrawn" in comments (approximate match)
Status:
Investigational
Source:
NCT01480479: Phase 3 Interventional Completed Glioblastoma
(2011)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02833506: Phase 1 Interventional Withdrawn Recurrent Fallopian Tube Carcinoma
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00090493: Phase 2/Phase 3 Interventional Completed Multiple Myeloma
(2004)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02279498: Phase 3 Interventional Completed Exocrine Pancreatic Insufficiency
(2015)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01777243: Phase 1 Interventional Completed Amyloidosis
(2013)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02279498: Phase 3 Interventional Completed Exocrine Pancreatic Insufficiency
(2015)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03703505: Phase 1 Interventional Completed Healthy Volunteers
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00418795: Phase 2/Phase 3 Interventional Completed Acute Intermittent Porphyria
(2003)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03719586: Phase 2/Phase 3 Interventional Completed Ebola Virus
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:porgaviximab [INN]
Source URL:
Class:
PROTEIN
